UK Public Sector Contracts & Tenders

NHS Wales Shared Services Partnership (NWSSP) Surgical Materials Testing Laboratory (SMTL) department are seeking to renew their current contract for the provision of Endotoxin Testing Consumables and associated support requirements. The contract is required to ensure continuity of supply for critical testing activities carried out within the SMTL department and to support ongoing operational and regulatory compliance requirements. NWSSP intends to undertake an Open Tender procedure in accordance with the Procurement Act 2023 to ensure a fully compliant, transparent, and fair procurement process. The procurement will provide all interested and suitably qualified suppliers with the opportunity to participate and submit a tender response.

Velindre University NHS Trust seeks to appoint a professional artist to design and create eight wall-based artworks for the radiotherapy treatment room mazes at the new Velindre Cancer Centre

Velindre University NHS Trust wishes to appoint a professional artist to produce a standalone sculpture to be located in the grounds of the new Velindre Cancer Centre. The sculpture will provide a focal point in the landscape and supporting wayfinding and orientation by drawing people towards the building.

Velindre University NHS Trust wishes to appoint a professional artist to design and create a wall artwork of bespoke, ceramic glazed tiles, enamelled panels or tiles for the breakout space in the Collaborative Centre of the New Velindre Cancer Centre.

NHS Wales Shared Services Partnership (NWSSP) Laundry Service requires fire stopping remediation works at its Swansea and North Wales Laundry Production Units. The works are required to reinstate fire compartmentation integrity where breaches have been identified through survey activity. The successful contractor will provide all labour, materials, equipment, testing, certification, documentation and warranties necessary to complete the fire stopping works. Works will include sealing service penetrations, linear joints, voids and cavities using appropriately tested and third-party certified systems. Full certification, photographic evidence and fire stopping registers will be required upon completion.

NHS Wales Shared Services Partnership Procurement Services (NWSSP-ProcS), hosted by Velindre NHS Trust, intends to undertake a procurement activity for the provision of Pathology Consumables, Equipment, and Instruments. The scope is expected to include, but not be limited to, laboratory plasticware and glassware, small equipment and apparatus, biopsy consumables, mortuary consumables and microscopy consumables. NWSSP-ProcS invites interested suppliers to participate in this early engagement exercise and to request a short questionnaire relating to the opportunity. The following NHS Wales organisations are expected to be included within the opportunity: Aneurin Bevan University Health Board, Betsi Cadwaladr University Health Board, Cardiff and Vale University Health Board, Cwm Taf Morgannwg University Health Board, Hywel Dda University Health Board, Public Health Wales NHS Trust, Swansea Bay University Health Board, Velindre NHS Trust, including the Surgical Material Testing Laboratory (SMTL) and Welsh Blood Service. Interested parties are invited to contact NWSSP-ProcS to request the questionnaire and provide their organisation's details for participation in the engagement exercise.

NHS Wales Shared Services Partnership (NWSSP) has an ongoing requirement for the provision of fully managed commercial storage facilities and associated distribution services for medical consumables, primarily pandemic Personal Protective Equipment (PPE) resilience stock.

NHS Wales Shared Services Partnership (NWSSP), hosted by Velindre University NHS Trust, are issuing this Market Engagement Notice to engage with the suppliers to gather feedback on market capabilities and capacity for the provision of managed services to support the operation of a finance, procurement and warehouse management system. The Central Team eBusiness Services (CTeS), within NWSSP, manage and supervise several core national enterprise systems which are used by Health Boards, Trusts, Special Heath Authorities, and Hosted Organisations, in Wales. These systems are collectively known as the FMS Enterprise System and include: - An e-Business Application System, including auxiliary services, which is facilitated through the Oracle eBusiness suite. - A Business Intelligence (BI) reporting system, facilitated through Qlik Sense. - An OCR Intelligent Scanning Management System - A Warehouse Management System - Other BI Reporting Systems The purpose of this market engagement exercise is to gather greater insight into the market’s capacity and capabilities in relation to provision of managed services and NWSSP are specifically seeking engagement from suppliers who are e-Business Suite experts with supply chain capabilities specifically covering warehouse management and who can also support to roll out and further development of discrete manufacturing processes within a regulated environment. The analysis of feedback obtained from this exercise will allow NWSSP to further develop its strategy and refine its service delivery requirements ahead of any potential procurement. The main objectives of this exercise are to: - Assess the level of interest in the marketplace from suppliers who can support the Oracle eBusiness Suite (EBS), - Test market capability and capacity, - Validate the proposed scope and service model, - Understand delivery approaches, innovations and commercial models and indicative rates, and - Explore development and innovation in relation to AI and the benefits that may be realised with its deployment through the Oracle eBusiness Suite. The provision of the Oracle EBS is facilitated through existing perpetual licences, and the scope of this engagement exercise does not include migrating the e-Business Application System to a Software as a Service (SaaS) model. This exercise is not a formal procurement process, does not constitute a call for competition and does not commit NHS Wales to any future procurement. However, information gathered through this engagement will help inform the development, scope and future direction of the project. Suppliers can express their interest in this process and request a copy of the Market Engagement Briefing Document, which contains further details on the requirement and engagement process, by contacting Chris Squires ([email protected]). When submitting an expression of interest, suppliers are requested to confirm that they acknowledge and understand that: - the proposed managed service requirement relates specifically to Oracle E-Business Suite (Oracle EBS) and does not include support for Software-as-a-Service (SaaS) solutions; - they have the necessary supply chain capabilities to support the requirements of the service; and - they possess the capability and expertise to support the development of warehouse management systems within discrete manufacturing environments. Suppliers will have the opportunity to participate in a structured engagement session which are scheduled for the 5th, 8th and 14th October. There are 10 sessions available and these will be allocated on a first come first served basis. However, NWSSP reserves the right, at its sole discretion, to make additional sessions available should there be sufficient interest from the market. No guarantee is given that additional sessions will be offered.

The Welsh Blood Service (WBS) requires the replacement of three rapid plasma / blast freezer units which are currently used for the rapid freezing of plasma components, including Fresh Frozen Plasma (FFP), cryoprecipitate, and Plasma for Medicines (PFM) components. The contract will provide WBS with the capability and business continuity required to manufacture clinical plasma for patients in Wales. It will also support the plasma for medicines programme in Wales as it continues to grow and expand on current plasma volumes produced.

NHS Wales Shared Services Partnership Procurement Services (NWSSP ProcS), hosted by Velindre NHS Trust, invites tenders on behalf of NHS Bodies across Wales for the appointment of suitably qualified suppliers to provide Quality Control Organisms, Lysis Buffer, and Bottled Media (Culture Media) under an All-Wales Framework Agreement. The Framework Agreement will have an initial duration from 1st January 2027 to end 31st August 2030, with an option to extend for a further two years, subject to a maximum total duration of five years and eight months. The procurement is divided into three Lots. Bidders may submit tenders for one, two, or all three Lots.

All Wales tender for Absorbents

NHS Wales Shared Services Partnership are looking for a suitably qualified supplier to carry out the Planned Preventative Maintenance (PPM), Servicing and Calibration of Centrifuges on behalf of the following Health Boards/Trusts: - Aneurin Bevan University Health Board - Betsi Cadwaladr University Health Board - Cwm Taf Morgannwg University Health Board - Hywel Dda University Health Board - Swansea Bay University Health Board - Welsh Blood Service (Including SMTL) - Public Health Wales Trust Contract pricing is to include Emergency Corrective Maintenance, including call outs, replacement parts, and the required calibrations to ensure laboratory compliance. Further information is to be found within the Specification and associated asset list provided as part of the tender pack.

The procurement of laryngoscope blades and their associated consumables. Products to be procured include laryngoscope blades & handles, bougies, airway exchange catheters, stylets, and video laryngoscopes.

Hywel Dda University Health Board (HDUHB) and Swansea Bay University Health Board (SBUHB), collectively the South West Wales region (the Region), seek to appoint service providers to undertake Integrated Pest Management services across the respective health boards’ sites. The contract will support a diverse estate portfolio, including acute hospitals, community hospitals, mental health units, community clinics, kitchens, waste compounds, external grounds, plant rooms, and other high risk or specialist areas. Preventative and reactive cover will be required, with sites classified based on risk. Carmarthenshire Sites: Approx 31 locations Pembrokeshire Sites: Approx 21 locations Ceredigion Sites: Approx 18 locations Swansea Sites: Approx 20 locations Neath Port Talbot Sites: Approx 11 locations The project is being led by both Health Boards, with HDUHB leading on the procurement process. Pre-Market Engagement (PME) will include two elements: 1. PME Questionnaire – to understand market interest and capacity, including testing appetite for lotting structure, and understanding any barriers that may prevent SMEs or local suppliers from participating in the procurement. The questionnaire will inform the procurement, including how NHS Wales Shared Services Partnership (NWSSP) can reduce barriers by welcoming suggestions regarding lotting, insurance, accreditation and contract requirements. The questionnaire is for market engagement purposes only and will not be used to assess, score, pre-qualify or exclude suppliers from this or any future procurement process. 2. PME Event – a virtual event where interested bidders can attend to learn more about the opportunity, including the anticipated procurement timetable and opportunities for suppliers to seek clarification ahead of tender publication. Your input would be very much appreciated to help inform the future direction and service model for integrated pest management in the Region. Estimated value is per annum. Contract duration is to be confirmed. This exercise does not commit either Health Board to undertake any future procurement. Participation in this exercise is entirely voluntary and will not provide any advantage or disadvantage in any subsequent procurement process.

This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.

This is a contract for the provision of Generic Injections/Infusions Drugs

All blood donors are required to answer a comprehensive pre-donation questionnaire to help in identifying potential risks to either the donor or recipients as a result of the donation.Welsh Blood Service are scoping the outsourcing of a digital tool that must include, but not be limited to, the following requirements; - Develop a digital questionnaire that can collect travel and residency information - Integrate with desktop user interface - Contain appropriate search functionality - Record the identity of the staff member conducting the screening and the date it was completed Full details of this Pre Market Engagement exercise are available upon request. The document must be requested by emailing [email protected]. The email subject must state "BLOOD DONOR ELIGIBILITY AND RISK ASSESSMENT SUPPORT. ". Interested suppliers are encouraged to request the documents as soon as possible.Interested parties must request, complete and return the documents [email protected] by 2pm on 11th September 2026. N.B.1. No estimated costs for the requirement are available at this stage. N.B.2. The estimated contract dates reflect the anticipated live programme date.

The Welsh Blood Service (WBS) is seeking to engage with the market regarding the future procurement of an advanced automated haematology analysis system to support blood donor assessment, blood component quality monitoring, research and innovation activities. The proposed solution will be required to provide automated full blood count (FBC) analysis, 5-part white cell differential capability and integrated reticulocyte analysis on the primary analyser. Of particular interest are systems capable of generating the data required to support emerging donor health assessment methodologies, including FlowScore calculation and reticulated haemoglobin analysis for the early detection of iron deficiency in blood donors. The future requirement is expected to include advanced analytical capabilities that support the unique operational needs of a blood establishment. These include fluorescence platelet counting with high accuracy at low platelet concentrations, reticulated platelet measurement, low-level white cell enumeration suitable for blood component quality monitoring, and the ability to perform blood component testing without the need for separate instrumentation. Suppliers should be able to demonstrate how their platforms support routine blood component quality control programmes through dedicated blood bank functionality and provide evidence of successful implementation within blood services, blood centres or comparable blood establishments. WBS is particularly interested in solutions that are supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking through sufficient participant numbers using the same analyser platform and methodology. Suppliers should be able to demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a mature quality management system and provide resilient service and maintenance arrangements that minimise downtime and ensure continuity of critical testing services. This notice is intended to inform the market of WBS's future requirements and to encourage engagement from suppliers capable of supporting the evolving needs of blood donor care, blood component quality assurance and transfusion medicine research. Interested parties are invited to email [email protected] with details of their suitable analyser by Tuesday 8th August 2026. We may engage further with interested parties once responses have been received.

Provision of Ophthalmology consumables and associated products, including Ophthalmic Surgical Consumables, Ophthalmic Implants and Devices, Ophthalmic Diagnostic and Treatment Consumables, and Ophthalmology Capital Equipment

Pre-market engagement notice for the upcoming tender opportunity for syringes and needles including: hypodermic safety needles, hypodermic needles, blunt fill needles, blunt filter needles, amniocentesis needles, luer slip syringes, luer lock syringes, catheter tip syringes, pre-filled syringes, insulin safety pen needles, insulin pen needles, acupuncture needles and NRfit needle products.